Literature DB >> 19925946

Epidemiology of rabies post-exposure prophylaxis--United States of America, 2006-2008.

Kira A Christian1, Jesse D Blanton, Michael Auslander, Charles E Rupprecht.   

Abstract

BACKGROUND: The United States of America (USA) does not have a national reporting system for rabies post-exposure prophylaxis (PEP). We describe the epidemiology of PEP in the USA so recommendations can be made during a PEP shortage.
METHODS: A two-part questionnaire designed to evaluate PEP distribution practices and estimate PEP use was administered to state health department representatives.
RESULTS: Seventy-five percent of participants responded that no public health guidance was needed to make a recommendation for PEP. The annual national average PEP use is 23,415 courses of PEP (range: 10,645-35,845).
CONCLUSION: PEP is loosely monitored and a precise estimate of PEP use is unknown. Improved national surveillance for PEP is needed.

Entities:  

Mesh:

Year:  2009        PMID: 19925946     DOI: 10.1016/j.vaccine.2009.09.028

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Clinical management and humoral immune responses to rabies post-exposure prophylaxis among three patients who received solid organs from a donor with rabies.

Authors:  N M Vora; L A Orciari; M Niezgoda; G Selvaggi; V Stosor; G M Lyon; R M Wallace; J Gabel; D R Stanek; P Jenkins; M Shiferaw; P Yager; F Jackson; C A Hanlon; I Damon; J D Blanton; S Recuenco; R Franka
Journal:  Transpl Infect Dis       Date:  2015-05-19       Impact factor: 2.228

2.  EVALUATION OF ORAL RABIES VACCINATION: PROTECTION AGAINST RABIES IN WILD CAUGHT RACCOONS ( PROCYON LOTOR).

Authors:  Jesse D Blanton; Michael Niezgoda; Cathleen A Hanlon; Craig B Swope; Jason Suckow; Brandi Saidy; Kathleen Nelson; Richard B Chipman; Dennis Slate
Journal:  J Wildl Dis       Date:  2018-03-29       Impact factor: 1.535

3.  Rabies prevention and management of cats in the context of trap-neuter-vaccinate-release programmes.

Authors:  A D Roebling; D Johnson; J D Blanton; M Levin; D Slate; G Fenwick; C E Rupprecht
Journal:  Zoonoses Public Health       Date:  2013-07-17       Impact factor: 2.702

4.  Serological Responses of Raccoons and Striped Skunks to Ontario Rabies Vaccine Bait in West Virginia during 2012-2016.

Authors:  Shylo R Johnson; Dennis Slate; Kathleen M Nelson; Amy J Davis; Samual A Mills; John T Forbes; Kurt C VerCauteren; Amy T Gilbert; Richard B Chipman
Journal:  Viruses       Date:  2021-01-22       Impact factor: 5.048

5.  Effectiveness of breed-specific legislation in decreasing the incidence of dog-bite injury hospitalisations in people in the Canadian province of Manitoba.

Authors:  Malathi Raghavan; Patricia J Martens; Dan Chateau; Charles Burchill
Journal:  Inj Prev       Date:  2012-06-30       Impact factor: 2.399

6.  Rabies in captive deer, Pennsylvania, USA, 2007-2010.

Authors:  Brett W Petersen; Danielle M Tack; Allison Longenberger; Aliza Simeone; Mària E Moll; Marshall P Deasy; Jesse D Blanton; Charles E Rupprecht
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

Review 7.  Management and modeling approaches for controlling raccoon rabies: The road to elimination.

Authors:  Stacey A Elmore; Richard B Chipman; Dennis Slate; Kathryn P Huyvaert; Kurt C VerCauteren; Amy T Gilbert
Journal:  PLoS Negl Trop Dis       Date:  2017-03-16

8.  Community survey after rabies outbreaks, Flagstaff, Arizona, USA.

Authors:  Andrea M McCollum; Jesse D Blanton; Robert C Holman; Laura S Callinan; Steven Baty; Randy Phillips; Michael Callahan; Craig Levy; Ken Komatsu; Rebecca Sunenshine; David L Bergman; Charles E Rupprecht
Journal:  Emerg Infect Dis       Date:  2012-06       Impact factor: 6.883

9.  Challenges facing human rabies control: the Lebanese experience.

Authors:  A Bizri; A Alawieh; N Ghosn; A Berry; U Musharrafieh
Journal:  Epidemiol Infect       Date:  2013-09-25       Impact factor: 4.434

10.  Low-incidence, high-consequence pathogens.

Authors:  Ermias D Belay; Stephan S Monroe
Journal:  Emerg Infect Dis       Date:  2014-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.